# Novo Nordisk CEO Defends Prices of Ozempic and Wegovy in US – Novo Nordisk CEO faced questions from Congress regarding the prices of Ozempic and Wegovy in the United States. – The company’s CEO defended the pricing of these weight loss medications in the US market. – Ozempic and Wegovy have shown significant effectiveness in aiding weight loss and managing obesity. – The CEO emphasized the investment in research and development that goes into creating these innovative medications. ### In conclusion, the CEO’s appearance before Congress shed light on the value and benefits of Ozempic and Wegovy in helping individuals on their weight loss journey. These medications may be a game-changer for many struggling with obesity, providing a safe and effective way to manage weight. To learn more about these innovative weight loss solutions, contact Mindful Evolution for personalized guidance and support on your wellness path. Weight loss disclaimer: Individual results may vary. Mindful Evolution provides telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact us at https://yourmindfulevolution.com or call or text us at 954-639-9960. —